Clinical Trials Logo

Clinical Trial Summary

The identification of mutations in cancer susceptibility genes is important as it makes it possible to recommend specific cancer treatments, implement risk reduction strategies or early detection of cancer, and identify family members at risk. The guidelines for evaluating patients who are candidates for genetic testing recommend pre-test genetic counseling. However, the limited number of specialists trained to provide genetic counseling worldwide, and particularly in developing countries such as Mexico, makes it difficult to implement such recommendations. The present proposal aims to compare, through a randomized non-inferiority study, a pre-test education strategy using a pre-recorded video against in-person counseling. This strategy could potentially increase access in places with limited resources. The general hypothesis of the research is that patients who are candidates for cancer genetic susceptibility testing who receive pre-test education via video will consent to genetic testing in the same proportion as those who receive it during an in-person visit. The specific objectives of the study include: 1) to compare the proportion of patients who are tested in both groups; 2) to assess knowledge about hereditary cancer in both groups after the intervention; 3) assess anxiety symptoms in both groups after the intervention; and 4) assess satisfaction with the information received during the intervention.Patients >18 years of age who meet the criteria for genetic testing to evaluate genetic cancer susceptibility genes and who have not previously undergone genetic testing or genetic counseling will be invited. The intervention group will receive education via pre-recorded video and the control group will receive genetic counseling during an in-person consultation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05805982
Study type Interventional
Source Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Contact
Status Completed
Phase N/A
Start date August 10, 2020
Completion date January 3, 2023

See also
  Status Clinical Trial Phase
Completed NCT03421327 - Genetic Risk: Whether, When, and How to Tell Adolescents
Enrolling by invitation NCT03319290 - Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies
Recruiting NCT04104230 - Quebec Pancreas Cancer Study
Completed NCT04242667 - Penn Biobank Return of Research Results Program N/A
Completed NCT03982446 - Germline Mutations in Pancreatic Adenocarcinoma
Active, not recruiting NCT03934606 - Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model
Completed NCT03067389 - Combined Breast Cancer Risk Study
Recruiting NCT06284330 - CHARGE Study: CHoice ARchitecture Genetic tEsting N/A
Recruiting NCT06073626 - Personalized Oncology Promoting Equity for Black Lives N/A
Completed NCT03081455 - Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes N/A
Recruiting NCT06157801 - Evaluation of Hereditary Cancer Educational Videos
Recruiting NCT04214210 - The DIALOGUE Study: Swiss-Korean Billateral Collaboration N/A
Recruiting NCT06378749 - Previvors Recharge: A Resilience Program for Cancer Previvors N/A